Raymond James Financial
MDT icon

Raymond James Financial’s Medtronic MDT Stock Holding History

Raymond James Financial’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$638M Sell
7,382,158
-3,871,453
-34% -$371M 0.2% 90
2025
Q4 		$1.08B Buy
11,253,611
+49,746
+0.4% +$4.83M 0.34% 45
2025
Q3 		$1.07B Buy
11,203,865
+327,899
+3% +$30.1M 0.34% 44
2025
Q2 		$948M Buy
10,875,966
+37,264
+0.3% +$3.16M 0.33% 50
2025
Q1 		$974M Buy
10,838,702
+163,536
+2% +$14.6M 0.37% 45
2024
Q4 		$853M Buy
+10,675,166
New +$924M 0.31% 53

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial's MDT Position: Q1 2026 in Review

Raymond James Financial reduced its Medtronic (MDT) stake by 34% in Q1 2026, selling an estimated $371M and leaving 7,382,158 shares worth $638M. The position accounts for 0.2% of the portfolio, ranked #90.

Raymond James Financial first reported a position in MDT in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.08B in Q4 2025. 2,237 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Raymond James Financial held 7,382,158 shares of Medtronic worth $638M as of Q1 2026.
  • Raymond James Financial sold 3,871,453 Medtronic shares in Q1 2026, an estimated $371M.
  • Medtronic made up 0.2% of Raymond James Financial's portfolio in Q1 2026, its #90 holding.
  • Raymond James Financial first reported a position in Medtronic in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Medtronic position peaked at $1.08B in Q4 2025.
  • 2,237 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.